Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
51.37
-1.31 (-2.49%)
Dec 5, 2025, 4:00 PM EST - Market closed
Soleno Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,759 | 1,938 | 1,228 | 16 | 33 | 154 | |
| Market Cap Growth | 23.55% | 57.88% | 7498.61% | -50.63% | -78.71% | 17.03% | |
| Enterprise Value | 2,256 | 1,656 | 1,176 | -3 | 5 | 98 | |
| Last Close Price | 51.37 | 44.95 | 40.25 | 1.98 | 6.15 | 28.95 | |
| PB Ratio | 5.58 | 7.91 | 7.79 | 1.56 | 1.84 | 3.37 | |
| P/TBV Ratio | 5.64 | 8.13 | 8.25 | - | 6.35 | 4.96 | |
| Debt / Equity Ratio | 0.11 | 0.22 | 0.00 | 0.02 | 0.03 | 0.00 | |
| Quick Ratio | 15.77 | 15.55 | 14.75 | 2.00 | 2.66 | 5.71 | |
| Current Ratio | 16.08 | 15.68 | 14.89 | 2.14 | 2.80 | 5.83 | |
| Return on Equity (ROE) | -20.66% | -87.35% | -46.45% | -171.05% | -97.60% | -81.46% | |
| Return on Assets (ROA) | -11.75% | -45.06% | -23.33% | -50.58% | -40.11% | -38.71% | |
| Return on Capital (ROIC) | -12.92% | -50.57% | -28.70% | -109.16% | -63.06% | -65.35% | |
| Return on Capital Employed (ROCE) | -14.90% | -59.10% | -22.90% | -130.90% | -117.10% | -56.70% | |
| Earnings Yield | -2.84% | -9.07% | -3.18% | -148.97% | -94.47% | -16.04% | |
| FCF Yield | -0.94% | -3.58% | -2.03% | -128.71% | -84.94% | -16.42% | |
| Buyback Yield / Dilution | -28.16% | -143.61% | -96.40% | -57.90% | -27.39% | -83.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.